Manufacturers report positive results for sovateltide vs standard of care for acute cerebral ischaemic stroke

At interim analysis in 2 phase III trials, patients on sovateltide (an endothelin-B receptor agonist) had an improved Modified Rankin Scale score of 2.40 (measures of the degree of disability or dependence on daily activities, range 0-6) vs an improvement of 1.64 for control.

Biospace Inc.